Morgan Joseph Initiates Coverage on Nektar Therapeutics (NKTR) with a Buy; PEG Technology & Pipeline Orchestrating Strong Comeback
Tweet Send to a Friend
Morgan Joseph initiates coverage on Nektar Therapeutics (Nasdaq: NKTR) with a Buy. Price target $7.
Morgan analyst says, "While Nektar ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "While Nektar ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
